drugset / Trial / NCT01102426
Aplidin - Dexamethasone in Relapsed/Refractory Myeloma
RandomizedParallel-groupOpen-labelTreatment
Summary
Study of Plitidepsin in combination with dexamethasone versus dexamethasone alone in patients with relapsed/refractory multiple myeloma.
Timeline
- Start
- 2010-06
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 40 mg | Oral |
| Subject | Plitidepsin | Peptide | 5 mg/m2 | Intravenous |